The WHO and other government agencies has put number of plans in production of vaccines.

The World Health Organization has announced that it will give millions of doses by year 2015 of Ebola. It will make history all over the world. The meeting held in Geneva, Switzerland in which WHO has announced that it will provide hundreds of thousands of doses by the end of June, 2015, which will help many nations in remission of Ebola virus. The departments and organizations have set the programs related to vaccine and funds to solve the issue of Ebola virus. Many high officials, regulatory and other bodies have discussed and planned to give precautions against Ebola virus. Vaccines trials may start in December, 2015 of EVD. Marie-Paule Kieny (the assistant director) said that hundreds of thousands vaccine could be provided by the mid of 2015. It’ll help many affected countries before the end of June, 2015.

Marie-Paul Kieny, WHO assistant director-general for health systems and innovation. Source: CNBC

Marie-Paul Kieny, WHO assistant director-general for health systems and innovation.
Source: CNBC

Trial of two vaccine candidates has been started and the rest of five other vaccine could be tested before the end of 2015, it is said by the Marie-Paul Kieny, WHO assistant director-general for health systems and innovation. Ebola had threatened the life of 10,000 people of October, 2015, it has been estimated by WHO.  Although it is an estimated rate but it varies in true figure because many of the cases are unreported. The only change can be brought through the working vaccine which will be a boon for the living beings suffering from Ebola.

People who are at death’s door will be back on one’s feet after the production of the vaccine. It will bring people around to pull through Ebola. It’ll be bringing patients in remission, they’ll not only cured but the new young generation on medication of the Ebola vaccine will not even take sick of EVD. By 19 October, 2014 people were infected by Ebola of Sierra Leone, Liberia and Guinea. Which lead to the death of more than 5000 people. The death rate has estimated by WHO, which is not a true figure.

Chimpanzee adenovirus vaccine and drug giant GlaxoSmithKline (GSK) vaccine are already filling a prescription. Adenovirus vaccine is developed by US, it contains Ebola protein (ChAd3). The organization of National Institute of Allergy and Infectious Diseases has created its name in the human history. GSK is being tested in US. The one of the largest dealing pharmaceutical companies on the planet is JOHNSON & JOHNSON, which has said that they have planned to have 250,000 vaccine doses to produce within May, 2015. The other company in the name of Mega Corp have plan to have 1,000,000 by next year. Vesicular stomatitis virus (rVSV) vaccine is also supporting in protection of Ebola virus. This vaccine is the production of Canada and licensed to New Link Genetics in Ames, Iowa. It is being tested in US to use it in Africa and Europe. It is said by the professor Jonathan Ball of virology at the University of Nottingham that it is difficult to test this vaccine.

As EVD is a nosocomial virus, which means it can be avoided by direct contact of contaminated surface, element of EVD patients.  More than 3,000 soldiers has been sent to Africa to work on this issue and they are protecting themselves by putting mask, hazmat suits and all the required protective objects and all. Lot of fund is required to work on this issue. More than $1,000,000 dollars has been spent in the production of vaccine.

 

A colorized, magnified electron microscope image of the Ebola virus growing out of an infected VERO 46 cell. Image by National Institute of Allerfy and Infectious Diseases Source: PBS newshour

A colorized, magnified electron microscope image of the Ebola virus growing out of an infected VERO 46 cell. Image by National Institute of Allerfy and Infectious Diseases
Source: PBS newshour

Apart from transmission of EVD through contaminated surface and elements it is also spreading through some of the aerosols (tiny airborne particles). If anyone comes in the contact to surface of active Ebola Virus Diseases it’ll be transferred from surface to the person. EVD enters in body through nasals, mouth, skin, and by mucus. EVD starts reacting between 2 days to 21 days. It destroys the main cells MONOCYTES, MACROPHAGES and DENDRITIC. Volunteers will be vaccinated first so, they will not get in touch with the EVD and it will help them to work in a better way. The first trial will be taken by Health care workers, who put themselves at risk all the time by helping Ebola patients.

The WHO has come first to take several measures against EVD. This made all to think of it and number of companies have started working on the production of vaccines and the various objects required to protect people

From EVD. Kieny said that money is not an issue because the government is supporting helping in such kinds of Efforts. $225 million has been committed by European government.